{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:25:01Z","timestamp":1792121101290,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ymthe.2019.08.011","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T19:48:46Z","timestamp":1567021726000},"page":"2147-2157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Gene Correction of LGMD2A Patient-Specific iPSCs for the Development of Targeted Autologous Cell Therapy"],"prefix":"10.1016","volume":"27","author":[{"given":"Sridhar","family":"Selvaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha R.","family":"Dhoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Judith","family":"Mateos-Aierdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheer","family":"Tungtur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Mondragon-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Killeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa K.P.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"L\u00f3pez de Munain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.R.","family":"Perlingeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2019.08.011_bib1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/WCO.0b013e32830efdc2","article-title":"Limb-girdle muscular dystrophies","volume":"21","author":"Guglieri","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jmg.2004.028738","article-title":"Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes","volume":"42","author":"Piluso","year":"2005","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ymthe.2019.08.011_bib3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.jnen.0000235854.77716.6c","article-title":"Limb-girdle muscular dystrophy in the United States","volume":"65","author":"Moore","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nmd.2004.10.008","article-title":"Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures","volume":"15","author":"Mercuri","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.08.011_bib5","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0002-9440(10)63551-1","article-title":"Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression","volume":"163","author":"Fanin","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1179\/174313209X380847","article-title":"The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)","volume":"32","author":"Angelini","year":"2010","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ymthe.2019.08.011_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","article-title":"Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A","volume":"81","author":"Richard","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.08.011_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2474-13-43","article-title":"Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies","volume":"13","author":"Hauerslev","year":"2012","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.ymthe.2019.08.011_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.nmd.2008.08.005","article-title":"Calpain 3, the \u201cgatekeeper\u201d of proper sarcomere assembly, turnover and maintenance","volume":"18","author":"Beckmann","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.08.011_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbadis.2006.07.002","article-title":"Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A)","volume":"1772","author":"Kramerova","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2019.08.011_bib11","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI40658","article-title":"Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy","volume":"120","author":"Ojima","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2019.08.011_bib12","doi-asserted-by":"crossref","first-page":"14493","DOI":"10.1074\/jbc.M610806200","article-title":"Myogenic stage, sarcomere length, and protease activity modulate localization of muscle-specific calpain","volume":"282","author":"Ojima","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2019.08.011_bib13","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/hmg\/ddw086","article-title":"Failure to up-regulate transcription of genes necessary for muscle adaptation underlies limb girdle muscular dystrophy 2A (calpainopathy)","volume":"25","author":"Kramerova","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.011_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jmb.2011.01.057","article-title":"Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles","volume":"407","author":"Ojima","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ymthe.2005.09.017","article-title":"Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A","volume":"13","author":"Bartoli","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.011_bib16","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCULATIONAHA.113.001340","article-title":"Restriction of calpain3 expression to the skeletal muscle prevents cardiac toxicity and corrects pathology in a murine model of limb-girdle muscular dystrophy","volume":"128","author":"Roudaut","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2019.08.011_bib17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2019.08.011_bib18","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.celrep.2017.06.005","article-title":"PAX7 Targets, CD54, Integrin \u03b19\u03b21, and SDC2, Allow Isolation of Human ESC\/iPSC-Derived Myogenic Progenitors","volume":"19","author":"Magli","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2019.08.011_bib19","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1073\/pnas.1103509108","article-title":"Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors","volume":"108","author":"Ban","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.011_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/geno.1997.5160","article-title":"Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development","volume":"48","author":"Fougerousse","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2019.08.011_bib21","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/erm.2016.9","article-title":"Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle","volume":"18","author":"Toral-Ojeda","year":"2016","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymthe.2019.08.011_bib22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0002-9440(10)65661-1","article-title":"Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A","volume":"153","author":"Anderson","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/humu.20058","article-title":"Molecular diagnosis in LGMD2A: mutation analysis or protein testing?","volume":"24","author":"Fanin","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2019.08.011_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbiotec.2015.04.024","article-title":"Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection","volume":"208","author":"Liang","year":"2015","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2019.08.011_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jmg.2006.044859","article-title":"Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations","volume":"44","author":"Fanin","year":"2007","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ymthe.2019.08.011_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13062-015-0035-z","article-title":"\u201cOff-Spotter\u201d: very fast and exhaustive enumeration of genomic lookalikes for designing CRISPR\/Cas guide RNAs","volume":"10","author":"Pliatsika","year":"2015","journal-title":"Biol. Direct"},{"key":"10.1016\/j.ymthe.2019.08.011_bib28","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2019.08.011_bib29","article-title":"Inference of CRISPR Edits from Sanger Trace Data","author":"Hsiau","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2019.08.011_bib30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/hmg\/ddh153","article-title":"Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in\u00a0vivo and in\u00a0vitro","volume":"13","author":"Kramerova","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.011_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/1074-7613(95)90047-0","article-title":"Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain","volume":"2","author":"Cao","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2019.08.011_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/301527a0","article-title":"A severe combined immunodeficiency mutation in the mouse","volume":"301","author":"Bosma","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.08.011_bib33","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2019.08.011_bib34","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/stem.1402","article-title":"A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation","volume":"31","author":"Arpke","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2019.08.011_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.08.011_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.08.011_bib37","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2019.08.011_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJMc1706274","article-title":"Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration","volume":"377","author":"Mandai","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.08.011_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.pbr.2017.02.008","article-title":"Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial","volume":"230","author":"Studer","year":"2017","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ymthe.2019.08.011_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","article-title":"Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson\u2019s Disease: Dawn of a New Era","volume":"21","author":"Barker","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2019.08.011_bib41","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/ncomms2550","article-title":"An ex\u00a0vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells","volume":"4","author":"Filareto","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2019.08.011_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2019.08.011_bib43","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.celrep.2016.05.016","article-title":"Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2019.08.011_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4939-8651-4_12","article-title":"Restoration of Dystrophin Protein Expression by Exon Skipping Utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells","volume":"1828","author":"Ifuku","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib45","doi-asserted-by":"crossref","first-page":"e1602814","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2019.08.011_bib46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2016.40","article-title":"Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy","volume":"24","author":"Turan","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.011_bib47","doi-asserted-by":"crossref","first-page":"140ra89","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2019.08.011_bib48","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mus.10368","article-title":"Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption","volume":"27","author":"Fougerousse","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.08.011_bib49","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1083\/jcb.151.7.1583","article-title":"Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha\/nuclear factor kappaB pathway perturbation in mice","volume":"151","author":"Richard","year":"2000","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib50","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.celrep.2018.10.067","article-title":"A Myogenic Double-Reporter Human Pluripotent Stem Cell Line Allows Prospective Isolation of Skeletal Muscle Progenitors","volume":"25","author":"Wu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2019.08.011_bib51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41556-017-0010-2","article-title":"ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs","volume":"20","author":"Hicks","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2019.08.011_bib52","series-title":"Large-Scale Expansion of Human iPSC-Derived Skeletal Muscle Cells for Disease Modeling and Cell-Based Therapeutic Strategies. Stem Cell Reports","first-page":"1975","volume":"10","author":"van der Wal","year":"2018"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619303946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619303946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:55:11Z","timestamp":1761501311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001619303946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1525001619303946"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene Correction of LGMD2A Patient-Specific iPSCs for the Development of Targeted Autologous Cell Therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}